Y. Nakashima

发表

Ramosetron Reduces Symptoms of Irritable Bowel Syndrome With Diarrhea and Improves Quality of Life in Women.

T. Okumura, K. Haruma, S. Fukudo, 2016, Gastroenterology.

Safety and effectiveness of peficitinib (ASP015K) in patients with rheumatoid arthritis: interim data (22.7 months mean peficitinib treatment) from a long-term, open-label extension study in Japan, Korea, and Taiwan

Sakae Tanaka, Yeong-Wook Song, Yoshiya Tanaka, 2020, Arthritis Research & Therapy.

Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male patients with irritable bowel syndrome with diarrhea

S. Fukudo, M. Ida, H. Akiho, 2017, BioPsychoSocial Medicine.

Evaluation of the irritable bowel syndrome severity index in Japanese male patients with irritable bowel syndrome with diarrhea

S. Fukudo, M. Ida, H. Akiho, 2017, BioPsychoSocial Medicine.

Effect of ramosetron on stool consistency in male patients with irritable bowel syndrome with diarrhea.

S. Fukudo, M. Ida, H. Akiho, 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Effect of ramosetron in female patients with irritable bowel syndrome with diarrhea: a phase III long-term study

T. Okumura, K. Haruma, S. Fukudo, 2016, Journal of Gastroenterology.

Effect of ipragliflozin on carotid intima-media thickness in patients with type 2 diabetes: a multicenter, randomized, controlled trial

K. Kario, M. Matsuhisa, K. Node, 2022, European heart journal. Cardiovascular pharmacotherapy.

Determining an optimal dose of linaclotide for use in Japanese patients with irritable bowel syndrome with constipation: A phase II randomized, double‐blind, placebo‐controlled study

S. Fukudo, A. Nakajima, H. Miwa, 2018, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Optimal dose of ramosetron in female patients with irritable bowel syndrome with diarrhea: A randomized, placebo‐controlled phase II study

M. Hongo, K. Haruma, S. Fukudo, 2017, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Safety and Efficacy of Reduced Prolonged-release Tacrolimus Exposure in De Novo Kidney Transplantation: A Randomized, Open-label, Pilot Study in Asia—OPTIMIZE Study

M. Kim, Y. Chiang, Y. Nakashima, 2019, Transplantation direct.

Randomized, double‐blind, placebo‐controlled study vs data in the daily practice using linaclotide in patients with irritable bowel syndrome with constipation

S. Fukudo, A. Nakajima, H. Miwa, 2018, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Lack of impact of ipragliflozin on endothelial function in patients with type 2 diabetes: sub-analysis of the PROTECT study

K. Kario, M. Matsuhisa, K. Node, 2023, Cardiovascular Diabetology.

Correction to: Safety and effectiveness of peficitinib (ASP015K) in patients with rheumatoid arthritis: interim data (22.7 months mean peficitinib treatment) from a long-term, open-label extension study in Japan, Korea, and Taiwan

Sakae Tanaka, Yoshiya Tanaka, T. Takeuchi, 2020, Arthritis Research & Therapy.